Skip to main content
. 2016 Jun 18;7(30):47431–47443. doi: 10.18632/oncotarget.10164

Table 1. Associations of the expression of CD133 and CD44 with the demographic data and clinicopathological characteristics in HCC patients.

Variables Cases CD133 expression P values CD44 expression P values
Low High Low High
Age, years
 < 52 38 15 23 0.084 19 19 0.337
 ≥ 52 36 16 20 14 22
Sex
 Male 64 24 40 1.000 27 37 0.502
 Female 10 7 3 6 4
HBsAg
 Negative 11 10 1 0.444 4 7 0.294
 Positive 63 21 42 29 34
HBeAg
 Negative 58 19 39 0.471 27 31 0.979
 Positive 16 12 4 6 10
Liver cirrhosis
 No 13 7 6 0.006 7 6 0.460
 Yes 61 24 37 26 35
Tumor differentiation 1.000 0.552
 I–II 55 26 29 23 32
 III–IV 19 5 14 10 9
Tumor stage 0.519 0.945
 I–II 44 32 12 20 24
 III–IV 30 23 7 12 18
Tumor size 0.305 0.066
 > 5 cm 8 6 2 2 6
 ≦ 5 cm 66 49 17 30 36
Tumor number 0.960 0.404
 1–2 71 52 19 31 40
 ≥ 3 3 3 0 1 2
AFP1 (ng/ml) 0.368 0.176
 < 40 48 28 20 24 24
 ≥ 40 26 3 23 9 17
ALT2 (U/l) 0.301 0.243
 < 75 32 12 20 10 22
 ≥ 75 42 19 23 21 21
Child-Pugh 1.000 1.000
 A 70 27 43 31 39
 B 4 4 0 2 2
1

AFP, a-fetoprotein.

2

ALT, alanine aminotransferase.